Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Gyre Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −6 vs. Q2 2022
- Shares held
- 7.73M
- −300.1K (−3.7%) vs. Q2 2022
- Total value
- $3.90M
- −$10.3M (−72.6%) vs. Q2 2022
- New holders
- 3
- 8 more added
- Sold out
- 9
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 176 | $0 | 0.00% | −20−10.2% | Reduced |
| American Portfolios Advisors | 215 | $108 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 321 | $162 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,076 | $1.00K | 0.00% | +892+75.3% | Added |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 5,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,100 | $7.00K | 0.00% | −10,000−43.3% | Reduced |
| Colorado Capital Management, Inc. | 13,712 | $7.00K | 0.01% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,609 | $7.00K | 0.00% | +13,609 | New |
| Prudential Financial Inc | 20,400 | $10.0K | 0.00% | 00.0% | Unchanged |
| Stephens Inc | 21,525 | $11.0K | 0.00% | −15,260−41.5% | Reduced |
| Bank of America Corp | 22,484 | $11.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 30,102 | $15.0K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 32,528 | $17.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 36,107 | $18.0K | 0.00% | −448−1.2% | Reduced |
| Commonwealth Equity Services, LLC | 40,515 | $20.0K | 0.00% | +30,515+305.2% | Added |
| Raymond James & Associates | 46,120 | $23.0K | 0.00% | +13,620+41.9% | Added |
| Lazard Asset Management LLC | 45,972 | $23.0K | 0.00% | +45,972 | New |
| Group One Trading, L.P. | 48,560 | $24.0K | 0.00% | +48,560 | New |
| Citadel Advisors LLC | 61,197 | $31.0K | 0.00% | −14,683−19.4% | Reduced |
| Johnson & Johnson | 66,951 | $34.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 72,599 | $37.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 86,412 | $44.0K | 0.00% | +1,881+2.2% | Added |
| Kynam Capital Management, LP | 90,188 | $45.0K | 0.01% | −3,246−3.5% | Reduced |
| Goldman Sachs Group Inc | 91,341 | $46.0K | 0.00% | −27,803−23.3% | Reduced |
| RBF Capital, LLC | 102,095 | $51.0K | 0.00% | −30,301−22.9% | Reduced |
| BlackRock Inc. | 179,547 | $90.0K | 0.00% | +3,214+1.8% | Added |
| Virtu Financial LLC | 189,175 | $95.0K | 0.01% | +135,198+250.5% | Added |
| Bank of New York Mellon Corp | 202,146 | $102.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 275,265 | $138.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 894,722 | $451.0K | 0.00% | +557,388+165.2% | Added |
| Renaissance Technologies LLC | 1,101,270 | $555.0K | 0.00% | +304,284+38.2% | Added |
| Vanguard Group Inc | 1,373,012 | $692.0K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 2,554,735 | $1.29M | 0.13% | −201,168−7.3% | Reduced |
| Madison Avenue Partners, LP | 0 | $0 | 0.00% | −1,006,300−100.0% | Sold out |
| Essex Woodlands Management, Inc. | 0 | $0 | 0.00% | −78,622−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,367−100.0% | Sold out |
| Black Diamond Financial, LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,682−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |